ArticleFrontiers in neurology2018
Multiple Sclerosis in the Asia Pacific Region: A Systematic Review of a Neglected Neurological Disease.
Article in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The prevalence of multiple sclerosis (MS) in Oceania, a systematic review, and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024Pooled it
- Game-based and gamification-enhanced telerehabilitation for physical therapy in people with multiple sclerosis: a scoping review.Biomedical engineering online · 2026Article
- Mapping the Evidence on Cardiovascular Disease Risk among Individuals Experiencing Disability: A Scoping Review.American journal of physical medicine & rehabilitation · 2026Article
- Article
- White matter hyperintensity segmentation of multiple sclerosis and neuromyelitis optical spectrum disorders using 2.5D FrC-ResUnet.Quantitative imaging in medicine and surgery · 2025Article
- Global, regional, and national trends and burden of multiple sclerosis in adolescents and young adults: a data analysis from 1990 to 2021 and projections to 2040.Frontiers in immunology · 2025Article
- Epidemiology and Healthcare Utilization in Pediatric Multiple Sclerosis and Neuromyelitis Optica: A Nationwide Population-Based Study in South Korea (2016-2020).Children (Basel, Switzerland) · 2024Article
- Prevalence of neuromyelitis optica spectrum disorder in the United States.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024Article
- Article
- [Effectiveness and tolerance of azathioprine as first-line treatment for multiple sclerosis: a case study from Morocco].The Pan African medical journal · 2024Article
- Article
- Multiple Sclerosis in Mongolia; the First Study Exploring Predictors of Disability and Depression in Mongolian MS Patients.Pathophysiology : the official journal of the International Society for Pathophysiology · 2023Article
- NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand.Journal of neurology · 2022Article
- Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target.Frontiers in immunology · 2022Review
- Cost-effectiveness of ocrelizumab for treatment of Iranian patients with relapsing multiple sclerosis.Current journal of neurology · 2021Article
- Epidemiology, treatment patterns and healthcare utilizations in multiple sclerosis in Taiwan.Scientific reports · 2021Article
- Risk of Psychiatric Disorders in Multiple Sclerosis: A Nationwide Cohort Study in an Asian Population.Neuropsychiatric disease and treatment · 2021Article
- Altered Plasma Metabolic Profiles in Chinese Patients With Multiple Sclerosis.Frontiers in immunology · 2021Article
- Familial Multiple Sclerosis in a Mother and Son Pair: A Sri Lankan and a South Asian First.Case reports in neurological medicine · 2021Article
- Corpus callosum index correlates with brain volumetry and disability in multiple sclerosis patients.Neurosciences (Riyadh, Saudi Arabia) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.